SIMONELLI, SARA
SIMONELLI, SARA
Dipartimento di Scienze Farmacologiche e Biomolecolari
A proteomic approach to identify novel disease biomarkers in LCAT deficiency
2018 S. Simonelli, A. Ossoli, C. Banfi, C. Pavanello, L. Calabresi, E. Gianazza
A woman with low HDL cholesterol and corneal opacity
2012 T. Lucchi, L. Calabresi, A. Pinto, E. Benetti, B. Arosio, S. Simonelli, R. Ratiglia, C. Vergani
Abdominal obesity negatively influences key metrics of reverse cholesterol transport
2022 J. Härdfeldt, M. Cariello, S. Simonelli, A. Ossoli, N. Scalpi, M. Piglionica, E. Pasculli, A. Noia, E. Berardi, P. Suppressa, G. Piazzolla, C. Sabbà, L. Calabresi, A. Moschetta
Acquired lecithin :cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease
2015 L. Calabresi, S. Simonelli, P. Conca, G. Busnach, M. Cabibbe, L. Gesualdo, M. Gigante, S. Penco, F. Veglia, G. Franceschini
Activation of naturally occurring LCAT mutants by a novel activator compound
2020 C. Pavanello, A. Ossoli, M. Turri, A. Strazzella, S. Simonelli, T. Laurenzi, K. Kono, K. Yamada, N. Kiyosawa, I. Eberini, L. Calabresi
CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency
2021 A. Ossoli, A. Strazzella, D. Rottoli, C. Zanchi, M. Locatelli, C. Zoja, S. Simonelli, F. Veglia, R. Barbaras, C. Tupin, J.-. Dasseux, L. Calabresi
Characterization of in vivo activity of a novel Lecithin:cholesterol acyltransferase inhibitor
2013 I. Zanotti, S. Simonelli, I. Eberini, C. Sensi, G. Lusardi, G. Franceschini, F. Bernini, L. Calabresi
Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3
2012 L. Pisciotta, E. Favari, L. Magnolo, S. Simonelli, M.P. Adorni, R. Sallo, T. Fancello, I. Zavaroni, D. Ardigo, F. Bernini, L. Calabresi, G. Franceschini, P. Tarugi, S. Calandra, S. Bertolini
Complete and partial LCAT deficiency are differentially associated with atherosclerosis
2018 F. Oldoni, D. Baldassarre, S. Castelnuovo, A. Ossoli, M. Amato, J. van Capelleveen, G.K. Hovingh, E. de Groot, A. Bochem, S. Simonelli, S. Barbieri, F. Veglia, G. Franceschini, J.A. Kuivenhoven, A.G. Holleboom, L. Calabresi
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
2017 M. Gomaraschi, A. Ossoli, S. Castelnuovo, S. Simonelli, C. Pavenello, G. Balzarotti, M. Arca, A. Di Costanzo, T. Sampietro, G. Vaudo, D. Baldassarre, F. Veglia, G. Franceschini, L. Calabresi
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients
2013 G. Franceschini, E. Favari, L. Calabresi, S. Simonelli, A. Bondioli, M. Adorni, F. Zimetti, M. Gomaraschi, K. Coutant, S. Rossomanno, E. Niesor, F. Bernini, R. Benghozi
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays
2014 C. Sensi, S. Simonelli, I. Zanotti, G. Tedeschi, G. Lusardi, G. Franceschini, L. Calabresi, I. Eberini
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
2011 M. Gomaraschi, L. Obici, S. Simonelli, G. Gregorini, A. Negrinelli, G. Merlini, G. Franceschini, L. Calabresi
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
2012 L. Calabresi, S. Simonelli, M. Gomaraschi, G. Franceschini
HDL and atherosclerosis : insights from inherited HDL disorders
2015 L. Calabresi, M. Gomaraschi, S. Simonelli, F. Bernini, G. Franceschini
Il trattamento con topiramato protegge i topi APOE-KO dall’insorgenza di danno renale senza modificare i livelli dei lipidi plasmatici
2019 M. Busnelli, S. Manzini, C. Parolini, L. Minoli, A. Ossoli, S. Simonelli, E. Brambilla, E. Lekka, A. Persidis, E. Scanziani, G. Chiesa
LCAT e spessore medio intimale carotideo in individui europei ad alto rischio cardiovascolare
2011 S. Simonelli, L. Calabresi, D. Baldassarre, M. Gomaraschi, M. Amato, S. Castelnuovo, B. Frigerio, A. Ravani, D. Sansaro, E. Mannarino, F. Veglia, C.R. Sirtori, G. Franceschini, E. Tremoli, O. behalf of the IMPROVE study
Low Plasma Lecithin : Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease
2020 A. Baragetti, A. Ossoli, A. Strazzella, S. Simonelli, I. Baragetti, L. Grigore, F. Pellegatta, A. Catapano, G. Norata, L. Calabresi
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia
2012 P. Conca, S. Pileggi, S. Simonelli, E. Boer, G. Boscutti, L. Magnolo, P. Tarugi, S. Penco, G. Franceschini, L. Calabresi, M. Gomaraschi
Paradoxical fall in proteinuria during pregnancy in an LCAT-deficient patient—A case report
2018 E.V. Hanna, S. Simonelli, S. Chamney, A. Ossoli, R.N. Mullan